title: [2014 update in general internal medicine].
abstract: This article comments 9 original publications from year 2014 of interest for the primary care physician in the outpatient setting. The impact of diet such as nut consumption on health outcomes and mortality is developped, and the importance of dietary changes while taking statins is reminded. Red flags in low back pain and their predictive value are re-evaluated. An association between benzodiazepine use and Alzheimer dementia seems probable. New treatments for alcohol abuse, restless legs syndrome and type 2 diabetes are discussed. Finally, β-bloquers' effects on respiratory function in asthmatic patients are beeing reexamined.
authors.forename: P
authors.initials: P
authors.lastname: Brander
authors.forename: S
authors.initials: S
authors.lastname: Amstutz
authors.forename: P
authors.initials: P
authors.lastname: Della Santa
authors.forename: T
authors.initials: T
authors.lastname: Favrod-Coune
authors.forename: A
authors.initials: A
authors.lastname: François
authors.forename: A
authors.initials: A
authors.lastname: Keta
authors.forename: S
authors.initials: S
authors.lastname: Pasche
authors.forename: T
authors.initials: T
authors.lastname: Wuillemin
authors.forename: J-M
authors.initials: JM
authors.lastname: Gaspoz
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000437:Alcoholism / Q000188:drug therapy; D000544:Alzheimer Disease / Q000139:chemically induced; D001249:Asthma / Q000188:drug therapy; D001416:Back Pain / Q000175:diagnosis; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004032:Diet; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007388:Internal Medicine / Q000639:trends*; D012148:Restless Legs Syndrome / Q000188:drug therapy
chemical_list: D000319:Adrenergic beta-Antagonists; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors